Volume | 27,779 |
|
|||||
News | - | ||||||
Day High | 1.00 | Low High |
|||||
Day Low | 0.96 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
ImmunoPrecise Antibodies Ltd | IPA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.9875 | 0.96 | 1.00 | 0.99 | 0.99 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
145 | 27,779 | US$ 0.96955 | US$ 26,933 | - | 0.94 - 3.2149 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:17:29 | 4 | US$ 1.00 | USD |
ImmunoPrecise Antibodies Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
24.8M | 25.05M | - | 20.67M | -26.56M | -1.06 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
ImmunoPrecise Antibodies News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IPA Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.10 | 1.14 | 0.95 | 1.05 | 103,023 | -0.09 | -8.18% |
1 Month | 1.25 | 1.36 | 0.95 | 1.13 | 81,024 | -0.24 | -19.20% |
3 Months | 1.49 | 1.64 | 0.95 | 1.33 | 110,135 | -0.48 | -32.21% |
6 Months | 1.15 | 2.60 | 0.95 | 1.74 | 338,243 | -0.14 | -12.17% |
1 Year | 2.95 | 3.2149 | 0.94 | 1.75 | 202,194 | -1.94 | -65.76% |
3 Years | 7.10 | 16.47 | 0.94 | 9.21 | 285,018 | -6.09 | -85.77% |
5 Years | 20.01 | 33.34 | 0.94 | 9.37 | 260,634 | -19.00 | -94.95% |
ImmunoPrecise Antibodies Description
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from the United States of America. |